Clinical Trial Update: A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement [Phase 4]

View source ↗

Summary

A Phase 4 multi-center study evaluating the long-term performance of the Summit Hip implant in primary total hip replacement has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Congenital Hip Dysplasia
• Nonunion of Femoral Fractures
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis
• Slipped Capital Femoral Epiphysis
• Traumatic Femoral Fractures

Drugs mentioned

• Summit Hip

Snippet

Sponsor: DePuy International | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: TERMINATED